FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labeling for this topica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Candidiasis
• Dermatophytosis
• Tinea Corporis
• Tinea Cruris
• Tinea Pedis

Drugs mentioned

• OXISTAT (OXICONAZOLE NITRATE)

Snippet

SUPPL AP for OXISTAT (OXICONAZOLE NITRATE)